ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
204
Frequently Asked Questions
What is Market Cap of ProKidney Corp - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. ProKidney Corp - Ordinary Shares - Class A market cap is $330.74M.
What is the 52-week high for ProKidney Corp - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ProKidney Corp - Ordinary Shares - Class A 52 week high is $7.13 as of September 16, 2025.
What is the 52-week low for ProKidney Corp - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ProKidney Corp - Ordinary Shares - Class A 52 week low is $0.4603 as of September 16, 2025.
What is ProKidney Corp - Ordinary Shares - Class A stock price today?
ProKidney Corp - Ordinary Shares - Class A stock price today is $2.62.
What was ProKidney Corp - Ordinary Shares - Class A stock price yesterday?
ProKidney Corp - Ordinary Shares - Class A stock price yesterday was $2.45.
What is the PE ratio of ProKidney Corp - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. ProKidney Corp - Ordinary Shares - Class A’s P/E ratio is -4.34.
What is the Price-to-Book ratio of ProKidney Corp - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. ProKidney Corp - Ordinary Shares - Class A P/B ratio is -0.3261.
What is the 50-day moving average of ProKidney Corp - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. ProKidney Corp - Ordinary Shares - Class A 50-day moving average is $2.80.
How many employess does ProKidney Corp - Ordinary Shares - Class A has?
ProKidney Corp - Ordinary Shares - Class A has 204 employees.
PROK ProKidney Corp